Transcripts from HERV-K HML-2 have been found to be associated with many cancers such as melanoma (Schiavetti et al., 2002) leukemia and lymphoma (Contreras-Galindo et al., 2008) as well as tumors of the breast (Pichon et al., 2006; Wang-Johanning et al., 2007) testis (Pichon et al., 2006) and ovary (Wang-Johanning et al., 2007). Here, CLEC10A is linked to melanoma.